A.R.T. Advisors’s Gossamer Bio GOSS Stock Holding History

A.R.T. Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-662	Closed	-$827K	–	432
2019 Q4	$827K	Buy	662 +429	+184%	+$691K	0.04%	638
2019 Q3	$312K	Buy	+233	New	+$371K	0.02%	1031

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

A.R.T. Advisors's GOSS Position: Q1 2020 in Review

A.R.T. Advisors sold out of Gossamer Bio (GOSS) in Q1 2020, closing a stake of 662 shares — an estimated $827K sold.

A.R.T. Advisors first reported a position in GOSS in Q3 2019 and held it in 2 quarters. The position peaked at $827K in Q4 2019. 96 funds tracked by Wall St. Rank hold GOSS as of Q1 2020.

A.R.T. Advisors reported no remaining Gossamer Bio position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 662 Gossamer Bio shares in Q1 2020, an estimated $827K.
A.R.T. Advisors first reported a position in Gossamer Bio in Q3 2019 and held it in 2 quarters.
A.R.T. Advisors's Gossamer Bio position peaked at $827K in Q4 2019.
96 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.